Cleared Traditional

K183440 - CRYOcheck FVIII Inhibitor Kit

K183440 is an FDA 510(k) clearance for CRYOcheck FVIII Inhibitor Kit, manufactured by Precision Biologic, Inc.. The device is a Class 2 Hematology device with product code GGP cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K183440 · Precision Biologic, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
90d
Days
Class 2
Risk

K183440 is an FDA 510(k) clearance for the CRYOcheck FVIII Inhibitor Kit. Classified as Test, Qualitative And Quantitative Factor Deficiency (product code GGP), Class II - Special Controls.

Submitted by Precision Biologic, Inc. (Darmouth, CA). The FDA issued a Cleared decision on March 12, 2019 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Precision Biologic, Inc. devices

FDA 510(k) Submission Details - K183440

510(k) Number K183440 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2018
Decision Date March 12, 2019
Days to Decision 90 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 113d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGP Device Classification - Class 2, Special Controls

Product Code GGP Test, Qualitative And Quantitative Factor Deficiency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGP Test, Qualitative And Quantitative Factor Deficiency

All 134
Devices cleared under the same product code (GGP) and FDA review panel - the closest regulatory comparables to K183440.
HemosIL von Willebrand Factor Antigen
K223402 · Instrumentation Laboratory CO · Dec 2022
HemosIL von Willebrand Factor Antigen
K200033 · Instrumentation Laboratory CO · Aug 2020
Cryocheck Chromogenic Factor VIII
K193204 · Precision Biologic · Jul 2020
INNOVANCE Free PS Ag
K181525 · Siemens Healthcare Diagnostics Products GmbH · Sep 2018
HEMOSIL VON WILLEBRAND ACTIVITY ASSAY
K133005 · Instrumentation Laboratory CO · Mar 2014
HEMOSIL PROTEIN S ACTIVITY ASSAY
K102164 · Instrumentation Laboratory CO · Mar 2011